Legend Capital, established in 2001 and based in Beijing, China, is a prominent venture capital firm and a subsidiary of Legend Holdings Ltd. The firm focuses on investing in high-growth ventures primarily within China or related markets, managing approximately US$700 million across multiple funds. Legend Capital emphasizes early-stage investments in the information technology sector, particularly in network applications and services, as well as in infrastructure and professional services. Additionally, it targets mid-market growth companies in consumer goods, clean technology, healthcare, equipment manufacturing, and modern services. With a portfolio of over 60 companies, Legend Capital actively supports its investments by providing extensive business resources and tailored services, aimed at enhancing business development and brand building in the Chinese market.
10/F, Tower A, Raycom Info.Tech Center, No.2 Ke Xue Yuan Nanlu, Zhong Guan Cun, Haidian District, Beijing 100190, China
Daqing Cai
Managing Director
Hao Chen
Managing Director and Head of Investment
Raymond CHEN
Co-Chief Investment Officer
Rui Chen
Managing Director
Frank Hong
Managing Director
Henry Ji
Executive Director
Yi Kang
Director
Richard Li
President
Jiaqing Li
Managing Director
Xiangyu Ouyang
Managing Director
Joon Sung Park
Executive Director
FAN Qihui
Executive Director
Jenking Shao
Managing Director and Partner
Zhenxing Shao
Partner / Managing Director
Jeff Wang
Managing Director
Junfeng Wang
Managing Director
Nengguang Wang
Managing Director and CFO
Piau-Voon Wang
COO
Tony WANG
VP
Ge Xinyu
Managing Director
Quan Zhou
Managing Director, Partner
Hank Zhou
Executive Director
Hongbin Zhou
Managing Director
William Wen
Executive Director
Past deals in Shanghai
DK Medtech
Series E in 2024
DK Medtech, founded in 2015 and headquartered in Suzhou, China, specializes in the development and production of balloon catheter medical devices. The company is recognized as a leader in the medical device industry, focusing on innovative technologies that aim to meet the evolving challenges in healthcare. Through its commitment to excellence, DK Medtech strives to create impactful solutions that enhance patient care and improve medical outcomes.
Chaitin Tech
Venture Round in 2024
Beijing Chaitin Tech Co., Ltd. (hereinafter referred to as Chaitin Tech) is a technology-oriented security company specialized in addressing Internet security problems. Boasting highly skilled security research team and technological R&D team, Chaitin Tech is committed to develop new network security technologies, so as to improve domestic security levels and keeping up with world-class technologies. The Company is currently mainly engaged in highly customized security services and security products, aiming at providing enterprises with effective custom security solutions through developing new technologies and methods, so as to thoroughly improve enterprises’ security defense capability.
Leapstack
Series C in 2023
Leapstack is an insurance technology company based in Shanghai, with additional offices in Beijing and Nanjing. Founded in February 2016, it focuses on developing big data artificial intelligence solutions tailored for commercial insurance companies and social security management agencies. The company's platform enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, anti-fraud measures, and compliance identification. By addressing inefficiencies in the industry, Leapstack aims to improve operational effectiveness and provide comprehensive data analysis and management tools for its clients.
Alioth
Series A in 2022
Elios focusing on the development and application of pharmaceutical process technology and related products. The company is dedicated to providing high-quality separation and purification solutions that comply with domestic and international regulations to pharmaceutical companies. In order to meet GMP requirements, Elios established its own production bases in Lingang, Shanghai, and Hangzhou. It has process development labs, verification labs, and filtration product R&D centers, as well as a research and development team led by membrane technology scientists to better safeguard supply chain security.
GalaxySpace
Series D in 2022
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.
Shuhai Supply Chain
Series B in 2022
Shuhai Supply Chain Logistics is a supply chain service provider specializing in solutions for the food industry, particularly catering businesses. Established in June 2011 and headquartered in Beijing, China, the company offers a comprehensive range of services that include sales, procurement, production, quality assurance, warehousing, and transportation. Shuhai operates a modern cold chain logistics center and food processing plants, ensuring the delivery of fresh and high-quality ingredients to restaurant owners. Recognized by industry authorities and customers alike, Shuhai has emerged as a benchmark enterprise in the supply chain field, highlighting its commitment to excellence in service delivery.
Nuclei System Technology
Venture Round in 2022
Nuclei System Technology is a pioneer in China for the commercialization of RISC-V processor licensing. The company focuses on the development of high-performance and low-power processors, along with their associated system-on-chip (SoC) platforms, aimed at meeting the increasing demand for embedded system applications globally. Nuclei's semiconductor technology is tailored for smart electronics, telecommunications, and computer processing cores. It specializes in creating configurable 32/64-bit RISC-V processors designed for artificial intelligence of things (AIoT) applications, thus delivering innovative solutions to its customers.
APTBIO
Series B in 2022
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.
TBSTest
Venture Round in 2022
TBSTest Technology is a developer and manufacturer of automatic test equipment for integrated circuits, specializing in ultra-large-scale integrated circuit testing. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an and Shanghai, as well as Suwon, South Korea, the company provides a comprehensive range of products, including test boards, software solutions, and memory systems. TBSTest Technology also offers pre-sales and after-sales support for its equipment, accessories, and software systems, along with application development projects. The company serves a diverse clientele, including clients engaged in integrated circuit design and production, as well as scientific research institutions and educational establishments.
Senscomm Semiconductor
Series A in 2022
Senscomm Semiconductor Co., Ltd. is a fabless semiconductor company founded in 2018 and based in Suzhou, China. The company focuses on developing and providing innovative semiconductor solutions for various applications, including augmented reality (AR), virtual reality (VR), the Internet of Things (IoT), and electric vehicles (EV). Since its inception, Senscomm has successfully launched over 20 products to meet the growing global demand in these high-tech sectors.
FIT2CLOUD
Series D in 2022
FIT2CLOUD, established in 2014, is a prominent provider of Multi-Cloud Management Platform solutions in China. The company focuses on enhancing the cloud management experience for enterprise customers navigating multi-cloud environments, addressing challenges related to IT operation security and continuous application delivery. FIT2CLOUD offers a range of products, including its Cloud Management Platform, JumpServer (an open-source fortress machine), DataEase (an open-source data visualization and analysis platform), and MeterSphere (an open-source continuous testing platform). Through these offerings, FIT2CLOUD enables enterprises to effectively manage and control their cloud services, thereby facilitating digital transformation and improving operational efficiency.
Medilink Therapeutics
Series B in 2022
MediLink Therapeutics is a biotechnology company based in Suzhou, China, specializing in the development of next-generation antibody-drug conjugates (ADCs). The company aims to address significant unmet medical needs in China by creating innovative therapeutics that target cancer while minimizing damage to healthy cells. MediLink Therapeutics is committed to enhancing patient outcomes through its research and development efforts, which include conducting multicenter clinical trials and engaging in cross-border collaborations to generate global value. By focusing on ADCs, the company strives to improve the efficacy of cancer treatments while ensuring patient safety during therapy.
Inceptio Technology
Series B in 2022
Inceptio Technology, founded in 2018 and based in Shanghai, China, specializes in the development of autonomous driving trucks aimed at transforming line-haul logistics. The company offers a nationwide freight network and provides a Transportation-As-A-Service model that enhances the security, efficiency, and cost-effectiveness of logistics operations. Utilizing advanced technologies such as artificial intelligence, new energy solutions, and logistics big data, Inceptio's heavy-duty trucks deliver innovative and safe logistics solutions tailored for logistics companies. Additionally, the company has established research and development centers in both Shanghai and Silicon Valley to further its technological advancements.
Hong Kong Asia Heart Centre
Series D in 2022
Hong Kong Asia Heart Centre is a cardiovascular specialist chain that provides various cardiovascular assessment and surgical services. Founded in 1999, The Hong Kong Asian Heart Center has a professional medical team with many years of experience in the treatment of heart disease.
Hoteam Software
Series C in 2022
Hoteam Software is a provider of intelligent manufacturing solutions aimed at transforming enterprise operations. The company emphasizes independent innovation and the development of controllable industrial software to support the advancement of China's industrial sector. Hoteam Software specializes in 3D software and offers a comprehensive range of services, including computer-aided design (CAD), computer-aided manufacturing (CAM), computer-aided process planning (CAPP), product data management (PDM), product lifecycle management (PLM), manufacturing execution systems (MES), warehouse management systems (WMS), and supplier relationship management (SRM). By leveraging its technology platforms, Hoteam Software enables industrial enterprises to enhance work efficiency and reduce operational costs through three-dimensional design, intelligent management, and visualization capabilities.
Zshield
Series C in 2022
Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.
Leapstack
Series C in 2021
Leapstack is an insurance technology company based in Shanghai, with additional offices in Beijing and Nanjing. Founded in February 2016, it focuses on developing big data artificial intelligence solutions tailored for commercial insurance companies and social security management agencies. The company's platform enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, anti-fraud measures, and compliance identification. By addressing inefficiencies in the industry, Leapstack aims to improve operational effectiveness and provide comprehensive data analysis and management tools for its clients.
Xbiome
Series B in 2021
Xbiome is a pioneering pharmaceutical company in China focused on intestinal micro-ecology, utilizing artificial intelligence to enhance gut health management for a population of 1.3 billion. The company specializes in developing microbial pharmaceuticals aimed at treating microecological intestinal disorders. By analyzing both patient and donor intestinal flora, Xbiome accelerates the creation of effective treatments. Their innovative approach includes the use of living biological drugs and microbial small molecule modulators, which aim to provide patients with relief from various gastrointestinal diseases.
ESWIN Computing
Series C in 2021
ESWIN Computing specializes in the research and development of RISC-V computing architecture, focusing on the design and testing of integrated circuits for Internet of Things (IoT) applications. The company develops chips used in display devices and wearable technology, providing comprehensive solutions in areas such as artificial intelligence, human-computer interaction, and the Internet of Vehicles. By combining innovative design with advanced materials, ESWIN Computing aims to enhance user experiences across various digital platforms.
Wuxi Biortus Biosciences
Series B in 2021
Wuxi Biortus Biosciences Co. Ltd. is a contract research organization based in Jiangyin, China, specializing in research and development services that support drug discovery. Founded in 2009, the company offers a range of services, including recombinant protein production, in vitro assays and screening, medicinal chemistry, structural biology, and target validation. Wuxi Biortus Biosciences is recognized for its commitment to quality and innovation, having established five advanced research platforms that enhance its capabilities in drug development. The company’s R&D team has developed various innovative techniques, some of which have been patented, further solidifying its role in the biotechnology sector. It operates as a subsidiary of Jiangsu Shuangliang Group Company Ltd.
H.Extract
Series C in 2021
H.Extract is a company focused on the research, development, promotion, and sales of pharmaceutical ERP solutions. As a leading brand in China's pharmaceutical distribution sector, H.Extract has implemented its Cloud ERP System in over 40,000 pharmacies nationwide. The company formed a strategic partnership with Tencent Cloud and WeChat Pay in 2016 to enhance the efficiency of the medicine distribution industry, particularly in pharmaceutical wholesale and chain drugstores. With 14 years of experience, H.Extract leverages its technical expertise and management skills to cater to a diverse client base, including major players in the pharmaceutical sector such as Harbin Pharmaceutical Group and Hainan Zhangzhongjing Dispensary. The company's commitment to innovation and high-quality service aims to streamline operations within the pharmaceutical supply chain.
LYNK Pharmaceuticals
Series B in 2021
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
Berry Oncology
Series B in 2021
Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis. It offers genetic diagnosis solutions from early diagnosis to mid-late monitoring that can solve clinical problems in the direction of several malignant tumors, providing patients with a higher quality of life and reduced risk of cancer. The company's mission is early diagnosis and early treatment of all tumors, all patients receive precise treatment. Along with its vision to become a global icon in the field of early screening and early diagnosis of tumors and a leader in China's tumor gene testing market.
Dearer Medical
Series B in 2021
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company emphasizes research and development to create both practical and fashionable color contact lenses, catering to a diverse customer base. Through its innovative approach, Dearer Medical aims to enhance the user experience while addressing the aesthetic and functional needs of contact lens wearers.
XSKY Data Technology
Series E in 2021
XSKY Beijing Data Technology Corporation Limited is a Chinese company that specializes in software-defined infrastructure products and services aimed at delivering innovative storage solutions for enterprises. By integrating internet carrier operations and mainstream open-source technologies, XSKY offers scalable storage solutions that facilitate cost-effective horizontal expansion for data centers. The company is a significant contributor to the open-source storage system Ceph, ranking among the top three globally and leading in China for source code contributions. Additionally, XSKY is the exclusive storage solution partner of Red Hat China and collaborates with major IT companies like Intel, Samsung, Dell, and Mellanox. Its products are utilized by early adopters in various sectors, including financial services, transportation, telecommunications, and energy, highlighting its commitment to enhancing data management and infrastructure innovation.
Liangyihui
Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. operates an authoritative online education and information platform focused on oncology. Based in Shanghai, China, the company collaborates with numerous reputable hospitals and institutions, both domestically and internationally, to address the information asymmetry in the cancer field. Liangyihui provides a comprehensive range of educational materials related to tumor treatment, including medical cases, conference information, online courses, and research reports. This platform serves as a valuable resource for oncologists and aims to enhance public understanding of cancer, promoting scientific knowledge and supporting efforts to prevent and combat the disease.
Exegenesis Bio
Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
MicuRx Pharmaceuticals
Series E in 2020
MicuRx Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering and developing antibiotics to address drug-resistant bacterial infections. Founded in 2007 and headquartered in Palo Alto, California, the company has established a hybrid business model that leverages U.S. research and development alongside cost-effective scientific resources in China. MicuRx's product lineup includes MRX-I, an oral antibiotic targeting multi-drug resistant gram-positive pathogens, and its intravenous prodrug form, MRX-IV. Additionally, the company offers MRX-V, an injectable antibiotic for gram-negative bacteria, and MRX-VIII, a polymyxin for gram-negative infections. The company is also working on a pipeline of antibacterial drugs aimed at combating both gram-positive and gram-negative bacterial pathogens. MicuRx's subsidiary, Shanghai MicuRx, is responsible for commercializing its agents in China while global clinical studies continue.
Xbiome
Series B in 2020
Xbiome is a pioneering pharmaceutical company in China focused on intestinal micro-ecology, utilizing artificial intelligence to enhance gut health management for a population of 1.3 billion. The company specializes in developing microbial pharmaceuticals aimed at treating microecological intestinal disorders. By analyzing both patient and donor intestinal flora, Xbiome accelerates the creation of effective treatments. Their innovative approach includes the use of living biological drugs and microbial small molecule modulators, which aim to provide patients with relief from various gastrointestinal diseases.
GalaxySpace
Series C in 2020
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.
LYNK Pharmaceuticals
Series A in 2020
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
Hemu (China) Biological Engineering
Series B in 2020
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.
Exegenesis Bio
Seed Round in 2020
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
ESWIN Computing
Series B in 2020
ESWIN Computing specializes in the research and development of RISC-V computing architecture, focusing on the design and testing of integrated circuits for Internet of Things (IoT) applications. The company develops chips used in display devices and wearable technology, providing comprehensive solutions in areas such as artificial intelligence, human-computer interaction, and the Internet of Vehicles. By combining innovative design with advanced materials, ESWIN Computing aims to enhance user experiences across various digital platforms.
Novast
Venture Round in 2020
Novast Holdings Ltd. is a multinational pharmaceutical company with operations in China and the United States, specializing in the research, development, and manufacture of FDA-inspected generic drugs. The company focuses on creating complex formulations that incorporate challenging active pharmaceutical ingredients (APIs) and offers product development services leveraging its expertise in novel technologies and drug delivery systems. Novast has established itself as a prominent player in the pharmaceutical industry in China, possessing unique capabilities in drug development, quality systems, and infrastructure. It collaborates with pharmaceutical and biotechnology companies to bring products to regulated markets, particularly the U.S. market, where it is recognized as a pioneer among Chinese companies selling pharmaceuticals locally. Novast also operates cGMP manufacturing facilities and has a management team experienced in securing numerous generic drug patents in the U.S., alongside independent research and development of innovative drug-delivery technologies.
Feiyu
Series A in 2020
Shanghai Feiyu Network Technology Co., Ltd. operates a live e-commerce platform specializing in the trading of used luxury products, particularly handbags. The company conducts live broadcasts showcasing various luxury brand handbags through its mobile application, allowing users to view the products in real-time and make purchases at lower prices. In addition to handbags, Feiyu's platform includes a range of luxury items such as bags, accessories, watches, footwear, and clothing, catering to the growing market for pre-owned luxury goods in China.
Suzhou Ribo Life Science
Series C in 2019
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.
Xbiome
Series B in 2019
Xbiome is a pioneering pharmaceutical company in China focused on intestinal micro-ecology, utilizing artificial intelligence to enhance gut health management for a population of 1.3 billion. The company specializes in developing microbial pharmaceuticals aimed at treating microecological intestinal disorders. By analyzing both patient and donor intestinal flora, Xbiome accelerates the creation of effective treatments. Their innovative approach includes the use of living biological drugs and microbial small molecule modulators, which aim to provide patients with relief from various gastrointestinal diseases.
dMed
Series B in 2019
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.
Mancando
Series A in 2019
Mancando is an automotive parts supplier based in Guangzhou, Guangdong, China, established in August 2015. The company specializes in providing a comprehensive range of car wearing parts essential for auto repair factories. Its product portfolio includes components for lubrication, braking, wiper, filtering, ignition, timing, and lighting systems. By integrating traditional auto parts management with internet and platform management, Mancando offers an innovative approach that allows customers to access all necessary automotive products from a single source.
GalaxySpace
Series B in 2019
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.
GKHT Medical Technology
Series C in 2019
Guoke Hengtai (Beijing) Medical Technology Co., Ltd., established in February 2013, is a company based in the Yizhuang Economic and Technological Development Zone of Beijing. It operates under the umbrella of Oriental Science and Technology Holding Group Co., Ltd., a subsidiary of the State-owned Assets Supervision and Administration Commission of the Chinese Academy of Sciences. The company specializes in the distribution and direct sales of medical devices, offering a range of professional services, including warehousing logistics, distribution channel management, and hospital SPD operation management. Since its inception, Guoke Hengtai has experienced significant growth, achieving a compound annual growth rate exceeding 50% over four years and embarking on an initial public offering journey in 2017.
AgotoZ
Series B in 2019
AgotoZ Technology, established in 2017 as Guanmai Technology (Beijing) Co., Ltd., specializes in providing high-speed network transmission services tailored for enterprises. The company focuses on WAN high-speed transmission core technology, big data computing, and security defense solutions. By leveraging its capabilities in resource calculation and security, AgotoZ aims to enhance the efficiency and interoperability of enterprise networks. Through independent research and development, it offers advanced technologies and products designed to meet the evolving needs of businesses seeking reliable and efficient network transmission solutions.
Shuhai Supply Chain
Series B in 2019
Shuhai Supply Chain Logistics is a supply chain service provider specializing in solutions for the food industry, particularly catering businesses. Established in June 2011 and headquartered in Beijing, China, the company offers a comprehensive range of services that include sales, procurement, production, quality assurance, warehousing, and transportation. Shuhai operates a modern cold chain logistics center and food processing plants, ensuring the delivery of fresh and high-quality ingredients to restaurant owners. Recognized by industry authorities and customers alike, Shuhai has emerged as a benchmark enterprise in the supply chain field, highlighting its commitment to excellence in service delivery.
River Security
Series B in 2019
River Security specializes in advanced cybersecurity solutions, focusing on fraud risk protection and dynamic application security. Established in 2012 with headquarters in Shanghai, Beijing, and Shenzhen, the company has developed innovative technologies that enhance the security of corporate website applications and safeguard business data. Its dynamic security bot-gate product utilizes a unique approach to predict server behavior by transforming the underlying code of web pages, allowing for more efficient and timely defenses against various modern cyber attacks. This technology represents a significant departure from traditional security methods, enabling businesses to reduce deployment and operational costs while improving overall security effectiveness.
Zongmu
Series C in 2019
ZongMu Technology, established in January 2013 and based in the Pudong ZhangJiang high-tech park of Shanghai, specializes in advanced driving assistance systems (ADAS) and autonomous driving technologies. The company has research and development centers located in Beijing and Shenzhen. ZongMu has gained a strong foothold in the Chinese automotive market by providing innovative SurroundView ADAS solutions, which include 2D and 3D panoramic vision systems, self-parking solutions, and driving recording systems. Through its commitment to quality and service, ZongMu has become a leading vendor in the SurroundView ADAS segment and has formed strategic partnerships with various original equipment manufacturers (OEMs) and their tier-one suppliers.
DeepWise
Series C in 2019
Beijing DeepWise Science and Technology Co., Ltd. specializes in artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and headquartered in Beijing, the company focuses on the early screening and diagnosis of various malignant diseases, including lung and breast cancer. It serves a diverse clientele, including hospitals, medical centers, and third-party imaging facilities. DeepWise's innovative software leverages advanced technology to improve diagnostic accuracy and efficiency, facilitating online consultations and data analysis through cloud-based solutions. By providing these services, DeepWise aims to support healthcare providers in both domestic and international markets in their efforts to detect and treat diseases effectively.
New Horizon Health
Series C in 2019
New Horizon Health develops advanced technology for the detection and screening of gastrointestinal cancers, with a primary focus on colorectal cancer. The company offers innovative products that utilize fecal gene analysis, allowing individuals to perform home tests that can identify signs of colon cancer and detect precancerous lesions more effectively than traditional blood tests. Established in 2015 and headquartered in Hangzhou, China, with an office in Beijing, New Horizon Health aims to enhance cancer screening accessibility through biotechnology. The company is dedicated to reducing cancer morbidity and mortality rates by promoting early detection and preventive measures, ensuring that high-quality health services reach households across the region. Its product lineup includes ColoClear and Pupu Tube, which are key revenue generators within its pipeline of screening solutions.
Neusoft Huiju
Series A in 2019
Beijing Neusoft Huiju Information Technology Co., Ltd. is an independent business unit of Neusoft and Donghua focusing on enterprise information solutions. The company was established in 2007 and currently has a staff of more than 1,000 people. Headquartered in Beijing, the company has six marketing centers, eight delivery centers, and three R&D centers across the country, as well as overseas operations in Japan and the United States.
Black Sesame Technologies
Series B in 2019
Black Sesame Technologies is an AI digital imaging technology firm founded in 2016, with locations in Silicon Valley and Shanghai. The company specializes in developing solutions for real-world AI challenges, focusing on image processing, computing images, and embedded sensing platforms. It provides advanced algorithms for applications in smartphones, autonomous driving, and various consumer electronics. The firm conducts extensive research and development, including core algorithm development, ASIC design, and software systems for advanced driver-assistance systems (ADAS). Black Sesame Technologies is committed to innovation, quality, and reliable service, leveraging the extensive industry experience of its team members. The company has designed automotive-grade system-on-chips (SoCs), including the high-computing Huashan Series and the cross-domain Wudang Series, aimed at enhancing intelligent vehicle solutions and driving the future of mobility.
Mancando
Series A in 2019
Mancando is an automotive parts supplier based in Guangzhou, Guangdong, China, established in August 2015. The company specializes in providing a comprehensive range of car wearing parts essential for auto repair factories. Its product portfolio includes components for lubrication, braking, wiper, filtering, ignition, timing, and lighting systems. By integrating traditional auto parts management with internet and platform management, Mancando offers an innovative approach that allows customers to access all necessary automotive products from a single source.
Tenry Pharmaceutical
Series B in 2019
Shanghai Tenry Pharmaceutical Company Limited operates two advanced manufacturing facilities in Shanghai, specializing in the production of biopharmaceuticals, pharmaceutical raw materials, and chemical drugs. The company is recognized as a technology-driven enterprise, focusing on the development and commercialization of innovative healthcare solutions. Tenry holds 73 nationally approved drugs and two biological agents, with its primary products aimed at bleeding and wound management. Through its commitment to research and development, along with regulatory compliance, Tenry strives to enhance patient care by providing effective treatment options.
Safe Medical Evaluation
Series C in 2018
Beijing Saifu Medical Research Institute Co., Ltd. relies on the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the National Drug Safety Evaluation and Research Center of the State of Beijing to establish strategic partnerships with them to form a combination of technology, capital and enterprise operations. The core members of the company are researchers of the Institute of Materia Medica of the Chinese Academy of Sciences and researchers of the Academy of Military Medical Sciences. They have high scientific research and academic status in the fields of drug research and development and toxicology research, as well as rich drug development, GLP management and technical experience, and build and operate the platform. Provides strong talent and technical support.
AoHua
Series D in 2018
Aohua is a global provider of endoscopy devices and solutions, specializing in the research, development, production, and sales of electronic endoscope equipment as well as endoscopic diagnostic and surgical consumables. Founded in 1994 and based in Shanghai, China, Aohua aims to lead in endoscope technology innovation and advance the progress of endoscopic diagnosis and treatment. The company is committed to enhancing medical practices through its advanced technological offerings in the endoscopy field.
Udesk
Series C in 2018
Udesk Ltd. is a customer experience solution provider based in Beijing, China, founded in 2014. The company offers an integrated platform that facilitates omnichannel communication, including call center operations, online customer service, and work order systems. Udesk enhances customer interactions across various channels such as text, mobile, phone, email, chat, and social media. Its solutions incorporate artificial intelligence, big data, and cloud computing technologies to improve customer relationship management and optimize marketing and customer success operations. Udesk serves a diverse range of industries, including healthcare, logistics, retail, education, and banking, among others. The company emphasizes connectivity and responsiveness to prioritize customer satisfaction.
Intelligence Indeed
Angel Round in 2018
Intelligence Indeed Co., Ltd. specializes in designing and developing intelligent software robots and chatbots aimed at automating enterprise processes. Founded in 2018 and based in Shenzhen, China, the company provides a range of solutions that enhance efficiency and reduce costs for businesses. Its offerings include finance solutions that incorporate risk control and self-service review systems, communication operation solutions for automating customer service tasks, and logistics solutions that facilitate cost estimation and information extraction. Additionally, Intelligence Indeed addresses complex decision-making challenges through its artificial intelligence and robotic process automation (RPA) technology, creating "smart assistant robots" utilized across various sectors, including finance and e-commerce.
Gaga Cafe
Series A in 2018
Gaga Café, founded in 2010 and headquartered in Shenzhen, China, operates a high-end café chain with a focus on providing a quality lifestyle experience. As of the first half of 2018, the company has expanded to 23 branches, including 21 independent locations and 2 partnerships with bookstores, strategically situated in key commercial areas of Shenzhen and Shanghai. The café chain is known for its menu featuring green and healthy options, including fresh fruit tea, brewed coffee, salads, pasta, handmade pizza, and a variety of snacks. Gaga Café has assembled a strong management team, attracting professionals from diverse backgrounds, including experienced food and beverage managers and IT specialists, all committed to enhancing the dining experience for its customers. The company is also exploring new restaurant concepts and collaborations with international food brands.
Chemclin
Private Equity Round in 2018
Chemclin Biotech is a Chinese technical service provider specializing in in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. The company develops, produces, and sells clinical immunochemiluminescence diagnostic testing reagents and instruments. Its services encompass a range of clinical inspection instruments, including chemiluminescence and biochemical reagents, as well as technical support, management, and certification. Additionally, Chemclin operates independent medical laboratories and is focused on introducing innovative diagnostic products and services to the Chinese market.
Qeebike
Series A in 2018
Qeebike Technology Co., Ltd, founded in October 2016 and headquartered in Hangzhou, China, specializes in electric bike rental and sharing services. The company offers a user-friendly mobile application that allows customers to hire, share, and unlock bikes conveniently using a QR code. It provides a high-capacity, high-performance ternary lithium battery, which lasts three times longer than typical electric vehicle batteries, thereby reducing operating costs and the frequency of replacements. Qeebike's service enables urban riders to navigate the city efficiently and safely, with adjustable pedaling and power modes, as well as a temporary parking feature for short breaks during rides. This innovative approach has led to a large volume of orders and significant profitability, presenting a viable transportation alternative for locals.
Editing and learning (CodePKU)
Series A in 2018
CodePKU Technology (Shenzhen) Co., Ltd. specializes in programming education for young learners, offering a variety of online courses that include subjects such as Scratch, Python, and preparation for the National Olympiad in Informatics. Established in 2012 in Shenzhen, China, the company provides both online and offline educational programs, training in children's products, and organizes programming competitions for youth. CodePKU also emphasizes international exchange programs and has developed an integrated educational technology system that combines technology research, curriculum development, and educational services. The initiative began as a project by a student team from the University of Tsukuba and has evolved into a successful venture focused on fostering creativity and technical skills among adolescents, contributing to their preparation for the global information age.
Spacety
Series B in 2018
Spacety is a microsatellite start-up that specializes in developing commercial micro/nano-satellites. It provides short-cycle, low-cost, and one-stop services to scientists, research institutes, and commercial companies, for science experiments and technology demonstrations. At present, the company has launched four commercial microsatellites and aims for more in the future. The company was founded in January 2016 with headquarters in Changsha, China.
Aikucun
Series B in 2018
Aikucun is a sales distribution company that provides fast and controllable inventory sales channels. As the micro-business purchasing channels have a certain privacy, completely independent of the traditional sales channels, and will not affect the brand's existing sales system. The brand owner can easily complete the inventory sales simply by sharing the inventory. Founded in 2017 by Shanghai Zhongdan Information Technology Co., Ltd., Aikucun is a crowdsourcing distribution platform.
Zongmu
Series C in 2018
ZongMu Technology, established in January 2013 and based in the Pudong ZhangJiang high-tech park of Shanghai, specializes in advanced driving assistance systems (ADAS) and autonomous driving technologies. The company has research and development centers located in Beijing and Shenzhen. ZongMu has gained a strong foothold in the Chinese automotive market by providing innovative SurroundView ADAS solutions, which include 2D and 3D panoramic vision systems, self-parking solutions, and driving recording systems. Through its commitment to quality and service, ZongMu has become a leading vendor in the SurroundView ADAS segment and has formed strategic partnerships with various original equipment manufacturers (OEMs) and their tier-one suppliers.
Goopal Group
Series A in 2018
Goopal Group, based in New York and founded in 2016, focuses on creating a comprehensive blockchain ecosystem by integrating advanced blockchain technology with practical industry applications. The company has established research and development centers in key global locations, including Hong Kong, Beijing, Singapore, and Luxembourg. Goopal Group provides a range of blockchain integrated services, including the development of public chains, blockchain forks, and contract technologies, as well as digital currency wallets and stable digital currencies. Additionally, the firm is involved in incubating promising blockchain projects and offers various ecosystem services to its clients, aiming to deliver innovative solutions that enhance users' experiences in the evolving blockchain landscape.
JollyChic
Series C in 2018
JollyChic is an e-commerce platform founded in 2012 by Aaron Li, headquartered in China. It specializes in the online retail of a diverse range of consumer products, including clothing, shoes, bags, babywear, home goods, electronics, and various accessories. The platform aims to provide quality and stylish products at competitive prices, catering to a broad customer base. JollyChic's offerings also extend to items such as toys, bedding, wedding supplies, and cleaning tools, making it a comprehensive destination for online shoppers seeking a variety of products.
Uoko.com
Series C in 2018
Uoko.com, operated by Sichuan UOKO Investment Management Co. Ltd., is an online property leasing platform based in Chengdu, China, founded in 2012. The platform specializes in apartment rental services, targeting young students and professionals in second-tier cities like Chengdu and Wuhan. Uoko.com offers standardized long-term rental apartments while also providing comprehensive property management solutions for homeowners. These services include post-rental offerings such as cleaning, maintenance, and renovation, enabling homeowners to effectively monetize their vacant properties. By focusing on high-quality rental options and community-oriented after-sales services, Uoko.com aims to meet the needs of urban rental groups and enhance the overall rental experience.
Innovent Biologics
Series E in 2018
Innovent Biologics, Inc. is a leading biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacture, and commercialization of monoclonal antibodies. The company focuses on various therapeutic areas, including oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody used in the treatment of several cancers, including Hodgkin’s lymphoma and esophageal carcinoma. Innovent is also developing a range of additional drug candidates, such as biosimilars for rituximab and adalimumab, as well as novel monoclonal antibodies targeting conditions like hypercholesterolemia and different types of cancer. With a robust pipeline and over 30 strategic collaborations with global pharmaceutical companies, Innovent is well-positioned in the biopharmaceutical landscape. The company's founders and management team bring extensive experience in biologics, having participated in the launch of notable products across international markets. Innovent was founded in 2011 and has established itself as a prominent player in the biotechnology sector in China.
Yosemite Clinic
Series A in 2018
Yosemite Clinic is a full-service clinic providing convenient walk-in medical services in a state-of-the-art environment in Central Pudong. They offer family medicine, internal medicine, surgery, orthopedics (sports medicine), dermatology, medical cosmetology, dentistry, gynecology, pediatrics, ophthalmology, anesthesiology, rehabilitation medicine, medical imaging, laboratory, pharmacy and more. Their onsite facilities and equipment include CT, X-ray, Ultrasound, Laboratory and Operating Rooms. Their doctors come from China and across the world, enabling us to serve you in many languages including, English, Japanese, Malay, Mandarin Chinese and Cantonese.
Youdao
Series A in 2018
Youdao develops and operates mobile applications by using big data technology. It allows users to search for web pages, images, news, music, blogs, and Chinese-to-English dictionary. Youdao began operation in 2007, with its headquarters in Beijing in China. It operates as a subsidiary of NetEase.
INXX
Series B in 2018
INXX operates an online retail platform that serves as a hub for local and international fashion brands, with a particular emphasis on high-end professional sportswear. The platform is designed to cater to fashion leaders and artists, providing them access to a diverse range of fashionable clothing and accessories. By bringing together artists, designers, and creators from various fields, INXX promotes street-wear culture in China, enabling consumers to discover and purchase high-quality fashion products efficiently. The company aims to create a trendy environment that fosters collaboration and innovation within the fashion industry.
Muniu Technology
Series A in 2018
Muniu Technology is a Beijing-based company that specializes in developing advanced radar sensor systems. The firm focuses on millimeter-wave radar technology, which enhances the precision of electronic instruments through sophisticated radar measurement capabilities. Muniu Technology offers a range of products, including long-distance data processors, GPS units, landing motion sensors, and ultra long-distance data receptors. These products are designed for various applications, such as drones, automobiles, security systems, and smart home technologies. By providing innovative sensor and smart control solutions, Muniu Technology supports industrial clients in enhancing their technological capabilities.
Pony.ai
Series A in 2018
Pony.ai, Inc. is a company specializing in the development of artificial intelligence software for autonomous vehicle technology. Founded in 2016 and headquartered in Fremont, California, with additional offices in San Francisco and China, Pony.ai focuses on creating systems that enable vehicles to navigate various driving conditions through advanced machine learning and algorithms. The company's technology enhances vehicle safety and functionality by accurately perceiving surroundings and predicting driver actions. In addition to its technology development, Pony.ai offers a public-facing Robotaxi service, showcasing its autonomous mobility solutions. The company collaborates with automotive manufacturers to integrate its innovative technology into commercial vehicles, contributing to the advancement of the autonomous driving industry.
YUNJI
Angel Round in 2017
Yunji is a documentary film production company in China.
Yanwen Express
Series B in 2017
Beijing YANWEN Logistics.Co.,Ltd is a specialized logistics company which was founded with the approval of the relevant competent government department, mainly including the International Logistics Department and the Department of Express, and each of them provide customized services to meet the need of different customers. From a small package to the goods of various forms and sizes, YANWEN Logistics is capable of serving customers by using aircraft, train, automobile and other transport tools with a professional transport management.
Ayshealth Technology
Series A in 2017
Ayshealth Technology, founded in 2014 and based in Beijing, China, specializes in developing a chronic disease management system. The company offers a guideline-based decision support (GDS) cloud service that aids physicians, patients, hospital managers, government entities, and insurance companies in monitoring and managing chronic disease data effectively. By leveraging artificial intelligence technologies, Ayshealth's platform enhances the diagnosis and treatment of chronic conditions, enabling healthcare professionals to make informed decisions and providing valuable data analytics to improve patient care.
Alo7
Series D in 2017
Alo7 is the leading provider of digital English Language Teaching (ELT) products and solutions in China, boasting over 10 million registered users and a network of more than 2,000 training school partners. The company operates an online tutoring platform designed to enhance English language learning for young Chinese students. By leveraging technology, Alo7 facilitates effective interactions among students, teachers, parents, and school administrators. The platform offers engaging and interactive classes that blend education with play, ensuring a high-quality learning experience. Alo7 is committed to transforming English education in China, redefining school management and fostering connections between educational institutions and homes in the mobile Internet era.
WeShine
Series B in 2017
WeShine is a Chinese gif picture sharing platform. The company claims that its service has covered over 800 million Chinese web users and its market share in Chinese GIF search engine has exceeded 90%.
Phoenix Travel Worldwide
Series C in 2017
Phoenix Travel Worldwide Co., Ltd. is a prominent international travel agency based in Beijing, China, specializing in outbound tourism services across Europe, the United States, Australia, Africa, and the Asia Pacific. Founded in 1997, the company has developed into a leading tourism resource integration enterprise in China, with a workforce exceeding one thousand employees and multiple branch offices in major cities including Shanghai, Chengdu, and Nanjing. Phoenix Travel is recognized as a 5A-level travel agency in Beijing and ranks among the top travel agencies nationally. The company offers a diverse portfolio of over 2000 tourist routes across more than 100 countries and regions, operating under four brands: Globaljoy, Mostour, Star Tour, and East Travel Holiday. In addition to its core outbound tourism services, Phoenix Travel also excels in high-end tourism, commercial tourism, airline ticketing, visa services, and various specialty travel experiences.
Vingoo Juice
Series B in 2017
Vingoo Juice specializes in creating autonomous machines designed for producing fresh orange juice, primarily targeting the community market in China. By employing a "whole fruit extraction" method, these machines maximize juice yield from each orange, providing customers with enhanced value. The company integrates advanced technologies such as cloud computing, artificial intelligence, and mobile payment systems to elevate the consumer experience, making the process of obtaining fresh juice both intuitive and efficient.
Ucpaas
Series B in 2017
Ucpaas is a provider of cloud communication services based in Shenzhen, China, focused on developing an open platform for converged communication solutions. The company offers a comprehensive cloud computing platform that integrates the capabilities of major telecommunications operators and Internet networks. By utilizing open REST APIs and client SDKs for various operating systems, Ucpaas enables developers and businesses to easily implement voice, SMS, VoIP, and video communication solutions without the burden of hardware or network costs. With over a decade of experience in the VoIP communications industry, Ucpaas has amassed a large user base and holds a significant share of telecommunications resources. The company's specialized team, composed of members with extensive backgrounds in telecommunications and technology, drives innovation and product development, ensuring that Ucpaas remains a competitive player in the digital communication landscape.
Zuoyebang
Series C in 2017
Zuoyebang is an online education startup based in Beijing, China, founded in 2014 by Hou Jianbin. The company focuses on providing educational products and services for primary and high school students, utilizing artificial intelligence to enhance learning experiences. Its platform allows students to upload homework questions and seek answers, making it easier for them to tackle study-related challenges. In addition to homework assistance, Zuoyebang offers online courses, live lessons, and evaluations for students from kindergarten through 12th grade. The company has gained significant backing from prominent investors, including Baidu, Alibaba Group, Tiger Global Management, SoftBank Vision Fund, Sequoia Capital China, and FountainVest Partners.
Dook Book
Series A in 2017
Dook Book is a book publisher that also has digital media and film operations. Dook Book is a professional cultural institution with influence, marketing model, and production mode in China's book industry . It is a two-wheel drive company with values and methodology. From 2009 to 2016, it has been listed on the list of Forbes China's Most Promising Enterprises for eight consecutive years. In 2016, Dook Book was officially established with the mission of “ inspiring personal growth ”, including stimulating the reader's spiritual growth, knowledge structure growth and survival skills growth.
PhiSkin
Series B in 2017
PhiSkin is a skin and laser clinic based in China, specializing in aesthetic medicine. The clinic offers a range of services, including aesthetic product injections such as Botox and hyaluronic acid, laser treatments, and non-surgical beauty procedures like double eyelid surgery. PhiSkin aims to provide customers with a comprehensive understanding of their skin conditions, along with tailored skincare solutions to meet individual needs.
Feiyu
Series A in 2017
Shanghai Feiyu Network Technology Co., Ltd. operates a live e-commerce platform specializing in the trading of used luxury products, particularly handbags. The company conducts live broadcasts showcasing various luxury brand handbags through its mobile application, allowing users to view the products in real-time and make purchases at lower prices. In addition to handbags, Feiyu's platform includes a range of luxury items such as bags, accessories, watches, footwear, and clothing, catering to the growing market for pre-owned luxury goods in China.
Qiang Sen International Community Medical
Series B in 2017
Qiang Sen International Community Medical (QSICM) operates community healthcare service centers. The Clinic offers internal medicine, pediatrics, gynecology, stomatology, laboratory, ultrasonography, and electrocardiography services. QSICM serves patients in China.
Suzhou Ribo Life Science
Series B in 2017
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.
Zongmu
Series B in 2017
ZongMu Technology, established in January 2013 and based in the Pudong ZhangJiang high-tech park of Shanghai, specializes in advanced driving assistance systems (ADAS) and autonomous driving technologies. The company has research and development centers located in Beijing and Shenzhen. ZongMu has gained a strong foothold in the Chinese automotive market by providing innovative SurroundView ADAS solutions, which include 2D and 3D panoramic vision systems, self-parking solutions, and driving recording systems. Through its commitment to quality and service, ZongMu has become a leading vendor in the SurroundView ADAS segment and has formed strategic partnerships with various original equipment manufacturers (OEMs) and their tier-one suppliers.
WeShine
Series A in 2016
WeShine is a Chinese gif picture sharing platform. The company claims that its service has covered over 800 million Chinese web users and its market share in Chinese GIF search engine has exceeded 90%.
AtourHotel
Series C in 2016
Atour Hotel, founded in 2012 and based in Shanghai, China, operates as an upper-midscale hotel chain that provides a range of hospitality services. The company generates revenue through franchise and management fees from its managed hotels, as well as through the operation of leased hotels and the sale of hotel supplies and retail products. With a focus on enhancing guest experiences, Atour Hotel is committed to establishing a strong presence in the competitive hospitality market in China. The company’s operational structure consists of a single segment known as the Atour Group, which encompasses its various hospitality offerings.
Quna
Series C in 2016
Quna operates an online media and information service platform in China with the goal of improving marketing and sales experiences. The company collaborates with large e-commerce operators and consumer goods enterprises to provide free-trial items to the public, allowing users to pay for their user experience at levels that satisfy them.
Innovent Biologics
Series D in 2016
Innovent Biologics, Inc. is a leading biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacture, and commercialization of monoclonal antibodies. The company focuses on various therapeutic areas, including oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody used in the treatment of several cancers, including Hodgkin’s lymphoma and esophageal carcinoma. Innovent is also developing a range of additional drug candidates, such as biosimilars for rituximab and adalimumab, as well as novel monoclonal antibodies targeting conditions like hypercholesterolemia and different types of cancer. With a robust pipeline and over 30 strategic collaborations with global pharmaceutical companies, Innovent is well-positioned in the biopharmaceutical landscape. The company's founders and management team bring extensive experience in biologics, having participated in the launch of notable products across international markets. Innovent was founded in 2011 and has established itself as a prominent player in the biotechnology sector in China.
Tangdou
Series B in 2016
Tangdou is a Chinese Senior Citizen Dance Video FirmTangdou Guangchangwu conducts dance lessons. The firm is headquartered in China..
Gfresh
Series A in 2016
Gfresh operates as a global online marketplace specializing in seafood trade. It offers a comprehensive platform that simplifies the process of buying and selling fresh seafood, enabling users to place orders and receive deliveries directly to their homes. The company enhances the trading experience by integrating essential services such as logistics, customs clearance, quality inspections, and order processing. For seafood exporters, Gfresh provides access to a vast market of buyers, particularly in China, allowing them to sell their products directly and with reduced risk. This innovative approach is transforming the seafood trading landscape, making it more efficient and accessible.
Tricorn
Seed Round in 2016
Tricorn (Beijing) Technology Co., Ltd., trading as trio.ai, is an Artificial Intelligence startup focused on developing a conversational platform that enables people to interact with various smart devices or virtual agents using natural language. Equipped with cutting-edge Machine Learning and Natural Language Processing technologies, Trio aims to provide world leading solutions in open-domain Chatbots and task-oriented Spoken Dialogue Systems, for IoT, enterprises and cyber entertainments.
Zuoyebang
Series B in 2016
Zuoyebang is an online education startup based in Beijing, China, founded in 2014 by Hou Jianbin. The company focuses on providing educational products and services for primary and high school students, utilizing artificial intelligence to enhance learning experiences. Its platform allows students to upload homework questions and seek answers, making it easier for them to tackle study-related challenges. In addition to homework assistance, Zuoyebang offers online courses, live lessons, and evaluations for students from kindergarten through 12th grade. The company has gained significant backing from prominent investors, including Baidu, Alibaba Group, Tiger Global Management, SoftBank Vision Fund, Sequoia Capital China, and FountainVest Partners.
Udesk
Series B in 2016
Udesk Ltd. is a customer experience solution provider based in Beijing, China, founded in 2014. The company offers an integrated platform that facilitates omnichannel communication, including call center operations, online customer service, and work order systems. Udesk enhances customer interactions across various channels such as text, mobile, phone, email, chat, and social media. Its solutions incorporate artificial intelligence, big data, and cloud computing technologies to improve customer relationship management and optimize marketing and customer success operations. Udesk serves a diverse range of industries, including healthcare, logistics, retail, education, and banking, among others. The company emphasizes connectivity and responsiveness to prioritize customer satisfaction.
Qiang Sen International Community Medical
Series A in 2016
Qiang Sen International Community Medical (QSICM) operates community healthcare service centers. The Clinic offers internal medicine, pediatrics, gynecology, stomatology, laboratory, ultrasonography, and electrocardiography services. QSICM serves patients in China.
New Horizon Health
Series A in 2016
New Horizon Health develops advanced technology for the detection and screening of gastrointestinal cancers, with a primary focus on colorectal cancer. The company offers innovative products that utilize fecal gene analysis, allowing individuals to perform home tests that can identify signs of colon cancer and detect precancerous lesions more effectively than traditional blood tests. Established in 2015 and headquartered in Hangzhou, China, with an office in Beijing, New Horizon Health aims to enhance cancer screening accessibility through biotechnology. The company is dedicated to reducing cancer morbidity and mortality rates by promoting early detection and preventive measures, ensuring that high-quality health services reach households across the region. Its product lineup includes ColoClear and Pupu Tube, which are key revenue generators within its pipeline of screening solutions.
SNH48
Series B in 2016
SNH48 is a Chinese idol girl group based in Shanghai, inspired by the concept of "idols you can meet." The group comprises numerous female members, primarily in their twenties, who engage in regular performances at their dedicated theater. SNH48 emphasizes fan interaction through various events, including handshake meetings and both online and offline activities. The group is owned by the Chinese companies NineStyle and Star48, and it operates as a platform for live performances and musical acts, fostering a strong connection between the performers and their audience.
AoHua
Series C in 2016
Aohua is a global provider of endoscopy devices and solutions, specializing in the research, development, production, and sales of electronic endoscope equipment as well as endoscopic diagnostic and surgical consumables. Founded in 1994 and based in Shanghai, China, Aohua aims to lead in endoscope technology innovation and advance the progress of endoscopic diagnosis and treatment. The company is committed to enhancing medical practices through its advanced technological offerings in the endoscopy field.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.